Literature DB >> 25645207

Novel gentamicin resistance genes in Campylobacter isolated from humans and retail meats in the USA.

Shaohua Zhao1, Sampa Mukherjee2, Yuansha Chen2, Cong Li2, Shenia Young2, Melissa Warren2, Jason Abbott2, Sharon Friedman2, Claudine Kabera2, Maria Karlsson3, Patrick F McDermott2.   

Abstract

OBJECTIVES: To understand the molecular epidemiology of gentamicin-resistant Campylobacter and investigate aminoglycoside resistance mechanisms.
METHODS: One-hundred-and-fifty-one gentamicin-resistant Campylobacter isolates from humans (n = 38 Campylobacter jejuni; n = 41, Campylobacter coli) and retail chickens (n = 72 C. coli), were screened for the presence of gentamicin resistance genes by PCR and subtyped using PFGE. A subset of the isolates (n = 41) was analysed using WGS.
RESULTS: Nine variants of gentamicin resistance genes were identified: aph(2″)-Ib, Ic, Ig, If, If1, If3, Ih, aac(6')-Ie/aph(2″)-Ia and aac(6')-Ie/aph(2″)-If2. The aph(2″)-Ib, Ic, If1, If3, Ih and aac(6')-Ie/aph(2″)-If2 variants were identified for the first time in Campylobacter. Human isolates showed more diverse aminoglycoside resistance genes than did retail chicken isolates, in which only aph(2″)-Ic and -Ig were identified. The aph(2″)-Ig gene was only gene shared by C. coli isolates from human (n = 27) and retail chicken (n = 69). These isolates displayed the same resistance profile and similar PFGE patterns, suggesting that contaminated retail chicken was probably the source of human C. coli infections. Human isolates were genetically diverse and generally more resistant than the retail chicken isolates. The most frequent co-resistance was to tetracycline (78/79, 98.7%), followed by ciprofloxacin/nalidixic acid (46/79, 58.2%), erythromycin and azithromycin (36/79, 45.6%), telithromycin (32/79, 40.5%) and clindamycin (18/79, 22.8%). All human and retail meat isolates were susceptible to florfenicol.
CONCLUSIONS: This study demonstrated that several new aminoglycoside resistance genes underlie the recent emergence of gentamicin-resistant Campylobacter, and that, in addition to contaminated retail chicken, other sources have also contributed to gentamicin-resistant Campylobacter infections in humans. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Campylobacter; NARMS; PCR; WGS; gentamicin resistance

Mesh:

Substances:

Year:  2015        PMID: 25645207     DOI: 10.1093/jac/dkv001

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

1.  High Prevalence and Predominance of the aph(2″)-If Gene Conferring Aminoglycoside Resistance in Campylobacter.

Authors:  Hong Yao; Dejun Liu; Yang Wang; Qijing Zhang; Zhangqi Shen
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Whole-Genome Sequencing Analysis Accurately Predicts Antimicrobial Resistance Phenotypes in Campylobacter spp.

Authors:  S Zhao; G H Tyson; Y Chen; C Li; S Mukherjee; S Young; C Lam; J P Folster; J M Whichard; P F McDermott
Journal:  Appl Environ Microbiol       Date:  2015-10-30       Impact factor: 4.792

3.  Cloning and Expression of Novel Aminoglycoside Phosphotransferase Genes from Campylobacter and Their Role in the Resistance to Six Aminoglycosides.

Authors:  S Zhao; S Mukherjee; C Li; S B Jones; S Young; P F McDermott
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Whole-Genome Sequence Analysis of Multidrug-Resistant Campylobacter Isolates: a Focus on Aminoglycoside Resistance Determinants.

Authors:  Adrien Fabre; Monica Oleastro; Alexandra Nunes; Andrea Santos; Elodie Sifré; Astrid Ducournau; Lucie Bénéjat; Alice Buissonnière; Pauline Floch; Francis Mégraud; Véronique Dubois; Philippe Lehours
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

5.  Antimicrobial Resistance in Campylobacter coli and Campylobacter jejuni from Human Campylobacteriosis in Taiwan, 2016 to 2019.

Authors:  Ying-Shu Liao; Bo-Han Chen; Ru-Hsiou Teng; You-Wun Wang; Jui-Hsien Chang; Shiu-Yun Liang; Chi-Sen Tsao; Yu-Ping Hong; Hui-Yung Sung; Chien-Shun Chiou
Journal:  Antimicrob Agents Chemother       Date:  2021-11-08       Impact factor: 5.938

6.  Complete Genome Sequences of Multidrug-Resistant Campylobacter jejuni Strain 14980A (Turkey Feces) and Campylobacter coli Strain 14983A (Housefly from a Turkey Farm), Harboring a Novel Gentamicin Resistance Mobile Element.

Authors:  William G Miller; Steven Huynh; Craig T Parker; Jeffrey A Niedermeyer; Sophia Kathariou
Journal:  Genome Announc       Date:  2016-10-20

Review 7.  National Antimicrobial Resistance Monitoring System: Two Decades of Advancing Public Health Through Integrated Surveillance of Antimicrobial Resistance.

Authors:  Beth E Karp; Heather Tate; Jodie R Plumblee; Uday Dessai; Jean M Whichard; Eileen L Thacker; Kis Robertson Hale; Wanda Wilson; Cindy R Friedman; Patricia M Griffin; Patrick F McDermott
Journal:  Foodborne Pathog Dis       Date:  2017-08-09       Impact factor: 3.171

8.  Highly Prevalent Multidrug-Resistant Campylobacter spp. Isolated From a Yellow-Feathered Broiler Slaughterhouse in South China.

Authors:  Jie Bai; Zhengquan Chen; Kaijian Luo; Fanliang Zeng; Xiaoyun Qu; Hongxia Zhang; Kaifeng Chen; Qijie Lin; Haishan He; Ming Liao; Jianmin Zhang
Journal:  Front Microbiol       Date:  2021-06-16       Impact factor: 5.640

9.  Whole Resistome Analysis in Campylobacter jejuni and C. coli Genomes Available in Public Repositories.

Authors:  José F Cobo-Díaz; Paloma González Del Río; Avelino Álvarez-Ordóñez
Journal:  Front Microbiol       Date:  2021-07-05       Impact factor: 5.640

10.  Phylogenetic and antimicrobial resistance gene analysis of Salmonella Typhimurium strains isolated in Brazil by whole genome sequencing.

Authors:  Fernanda Almeida; Amanda Aparecida Seribelli; Marta Inês Cazentini Medeiros; Dália Dos Prazeres Rodrigues; Alessandro de MelloVarani; Yan Luo; Marc W Allard; Juliana Pfrimer Falcão
Journal:  PLoS One       Date:  2018-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.